Diuretics and mortality in acute renal failure

Shigehiko Uchino, Gordon S. Doig, Rinaldo Bellomo, Hiroshi Morimatsu, Stanislao Morgera, Miet Schetz, Ian Tan, Catherine Bouman, Ettiene Macedo, Noel Gibney, Ashita Tolwani, Claudio Ronco, John A. Kellum

Research output: Contribution to journalArticle

231 Citations (Scopus)

Abstract

Objective: According to recent research, diuretics may increase mortality in acute renal failure patients. The administration of diuretics in such patients has been discouraged. Our objective was to determine the impact of diuretics on the mortality rate of critically ill patients with acute renal failure. Design: Prospective, multiple-center, multinational epidemiologic study. Setting: Intensive care units from 54 centers and 23 countries. Patients: Patients were 1,743 consecutive patients who either were treated with renal replacement therapy or fulfilled predefined criteria for acute renal failure. Interventions: Three distinct multivariate models were developed to assess the relationship between diuretic use and subsequent mortality: a) a propensity score adjusted multivariate model containing terms previously identified to be important predictors of outcome; b) a new propensity score adjusted multivariate model; and c) a multivariate model developed using standard methods, compensating for collinearity. Measurements and Main Results: Approximately 70% of patients were treated with diuretics at study inclusion. Mean age was 68 and mean Simplified Acute Physiology Score II was 47. Severe sepsis/septic shock (43.8%), major surgery (39.1), low cardiac output (29.7), and hypovolemia (28.2%) were the most common conditions associated with the development of acute renal failure. Furosemide was the most common diuretic used (98.3%). Combination therapy was used in 98 patients only. In all three models, diuretic use was not associated with a significantly increased risk of mortality. Conclusions: Diuretics are commonly prescribed in critically ill patients with acute renal failure, and their use is not associated with higher mortality. There is full equipoise for a randomised controlled trial of diuretics in critically ill patients with renal dysfunction. (Crit Care Med 2004; 32:1669-1677).

Original languageEnglish
Pages (from-to)1669-1677
Number of pages9
JournalCritical Care Medicine
Volume32
Issue number8
DOIs
Publication statusPublished - Aug 2004
Externally publishedYes

Fingerprint

Diuretics
Acute Kidney Injury
Mortality
Critical Illness
Propensity Score
Low Cardiac Output
Hypovolemia
Renal Replacement Therapy
Furosemide
Septic Shock
Intensive Care Units
Epidemiologic Studies
Sepsis
Randomized Controlled Trials
Kidney
Research

Keywords

  • Acute kidney failure
  • Critical illness
  • Diuretics
  • Epidemiology
  • Furosemide
  • Logistic regression modeling
  • Multicollinearity
  • Propensity scores
  • Renal replacement therapy

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Uchino, S., Doig, G. S., Bellomo, R., Morimatsu, H., Morgera, S., Schetz, M., ... Kellum, J. A. (2004). Diuretics and mortality in acute renal failure. Critical Care Medicine, 32(8), 1669-1677. https://doi.org/10.1097/01.CCM.0000132892.51063.2F

Diuretics and mortality in acute renal failure. / Uchino, Shigehiko; Doig, Gordon S.; Bellomo, Rinaldo; Morimatsu, Hiroshi; Morgera, Stanislao; Schetz, Miet; Tan, Ian; Bouman, Catherine; Macedo, Ettiene; Gibney, Noel; Tolwani, Ashita; Ronco, Claudio; Kellum, John A.

In: Critical Care Medicine, Vol. 32, No. 8, 08.2004, p. 1669-1677.

Research output: Contribution to journalArticle

Uchino, S, Doig, GS, Bellomo, R, Morimatsu, H, Morgera, S, Schetz, M, Tan, I, Bouman, C, Macedo, E, Gibney, N, Tolwani, A, Ronco, C & Kellum, JA 2004, 'Diuretics and mortality in acute renal failure', Critical Care Medicine, vol. 32, no. 8, pp. 1669-1677. https://doi.org/10.1097/01.CCM.0000132892.51063.2F
Uchino, Shigehiko ; Doig, Gordon S. ; Bellomo, Rinaldo ; Morimatsu, Hiroshi ; Morgera, Stanislao ; Schetz, Miet ; Tan, Ian ; Bouman, Catherine ; Macedo, Ettiene ; Gibney, Noel ; Tolwani, Ashita ; Ronco, Claudio ; Kellum, John A. / Diuretics and mortality in acute renal failure. In: Critical Care Medicine. 2004 ; Vol. 32, No. 8. pp. 1669-1677.
@article{f7d2c5ce5e394409a211682697406c64,
title = "Diuretics and mortality in acute renal failure",
abstract = "Objective: According to recent research, diuretics may increase mortality in acute renal failure patients. The administration of diuretics in such patients has been discouraged. Our objective was to determine the impact of diuretics on the mortality rate of critically ill patients with acute renal failure. Design: Prospective, multiple-center, multinational epidemiologic study. Setting: Intensive care units from 54 centers and 23 countries. Patients: Patients were 1,743 consecutive patients who either were treated with renal replacement therapy or fulfilled predefined criteria for acute renal failure. Interventions: Three distinct multivariate models were developed to assess the relationship between diuretic use and subsequent mortality: a) a propensity score adjusted multivariate model containing terms previously identified to be important predictors of outcome; b) a new propensity score adjusted multivariate model; and c) a multivariate model developed using standard methods, compensating for collinearity. Measurements and Main Results: Approximately 70{\%} of patients were treated with diuretics at study inclusion. Mean age was 68 and mean Simplified Acute Physiology Score II was 47. Severe sepsis/septic shock (43.8{\%}), major surgery (39.1), low cardiac output (29.7), and hypovolemia (28.2{\%}) were the most common conditions associated with the development of acute renal failure. Furosemide was the most common diuretic used (98.3{\%}). Combination therapy was used in 98 patients only. In all three models, diuretic use was not associated with a significantly increased risk of mortality. Conclusions: Diuretics are commonly prescribed in critically ill patients with acute renal failure, and their use is not associated with higher mortality. There is full equipoise for a randomised controlled trial of diuretics in critically ill patients with renal dysfunction. (Crit Care Med 2004; 32:1669-1677).",
keywords = "Acute kidney failure, Critical illness, Diuretics, Epidemiology, Furosemide, Logistic regression modeling, Multicollinearity, Propensity scores, Renal replacement therapy",
author = "Shigehiko Uchino and Doig, {Gordon S.} and Rinaldo Bellomo and Hiroshi Morimatsu and Stanislao Morgera and Miet Schetz and Ian Tan and Catherine Bouman and Ettiene Macedo and Noel Gibney and Ashita Tolwani and Claudio Ronco and Kellum, {John A.}",
year = "2004",
month = "8",
doi = "10.1097/01.CCM.0000132892.51063.2F",
language = "English",
volume = "32",
pages = "1669--1677",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Diuretics and mortality in acute renal failure

AU - Uchino, Shigehiko

AU - Doig, Gordon S.

AU - Bellomo, Rinaldo

AU - Morimatsu, Hiroshi

AU - Morgera, Stanislao

AU - Schetz, Miet

AU - Tan, Ian

AU - Bouman, Catherine

AU - Macedo, Ettiene

AU - Gibney, Noel

AU - Tolwani, Ashita

AU - Ronco, Claudio

AU - Kellum, John A.

PY - 2004/8

Y1 - 2004/8

N2 - Objective: According to recent research, diuretics may increase mortality in acute renal failure patients. The administration of diuretics in such patients has been discouraged. Our objective was to determine the impact of diuretics on the mortality rate of critically ill patients with acute renal failure. Design: Prospective, multiple-center, multinational epidemiologic study. Setting: Intensive care units from 54 centers and 23 countries. Patients: Patients were 1,743 consecutive patients who either were treated with renal replacement therapy or fulfilled predefined criteria for acute renal failure. Interventions: Three distinct multivariate models were developed to assess the relationship between diuretic use and subsequent mortality: a) a propensity score adjusted multivariate model containing terms previously identified to be important predictors of outcome; b) a new propensity score adjusted multivariate model; and c) a multivariate model developed using standard methods, compensating for collinearity. Measurements and Main Results: Approximately 70% of patients were treated with diuretics at study inclusion. Mean age was 68 and mean Simplified Acute Physiology Score II was 47. Severe sepsis/septic shock (43.8%), major surgery (39.1), low cardiac output (29.7), and hypovolemia (28.2%) were the most common conditions associated with the development of acute renal failure. Furosemide was the most common diuretic used (98.3%). Combination therapy was used in 98 patients only. In all three models, diuretic use was not associated with a significantly increased risk of mortality. Conclusions: Diuretics are commonly prescribed in critically ill patients with acute renal failure, and their use is not associated with higher mortality. There is full equipoise for a randomised controlled trial of diuretics in critically ill patients with renal dysfunction. (Crit Care Med 2004; 32:1669-1677).

AB - Objective: According to recent research, diuretics may increase mortality in acute renal failure patients. The administration of diuretics in such patients has been discouraged. Our objective was to determine the impact of diuretics on the mortality rate of critically ill patients with acute renal failure. Design: Prospective, multiple-center, multinational epidemiologic study. Setting: Intensive care units from 54 centers and 23 countries. Patients: Patients were 1,743 consecutive patients who either were treated with renal replacement therapy or fulfilled predefined criteria for acute renal failure. Interventions: Three distinct multivariate models were developed to assess the relationship between diuretic use and subsequent mortality: a) a propensity score adjusted multivariate model containing terms previously identified to be important predictors of outcome; b) a new propensity score adjusted multivariate model; and c) a multivariate model developed using standard methods, compensating for collinearity. Measurements and Main Results: Approximately 70% of patients were treated with diuretics at study inclusion. Mean age was 68 and mean Simplified Acute Physiology Score II was 47. Severe sepsis/septic shock (43.8%), major surgery (39.1), low cardiac output (29.7), and hypovolemia (28.2%) were the most common conditions associated with the development of acute renal failure. Furosemide was the most common diuretic used (98.3%). Combination therapy was used in 98 patients only. In all three models, diuretic use was not associated with a significantly increased risk of mortality. Conclusions: Diuretics are commonly prescribed in critically ill patients with acute renal failure, and their use is not associated with higher mortality. There is full equipoise for a randomised controlled trial of diuretics in critically ill patients with renal dysfunction. (Crit Care Med 2004; 32:1669-1677).

KW - Acute kidney failure

KW - Critical illness

KW - Diuretics

KW - Epidemiology

KW - Furosemide

KW - Logistic regression modeling

KW - Multicollinearity

KW - Propensity scores

KW - Renal replacement therapy

UR - http://www.scopus.com/inward/record.url?scp=3943071113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3943071113&partnerID=8YFLogxK

U2 - 10.1097/01.CCM.0000132892.51063.2F

DO - 10.1097/01.CCM.0000132892.51063.2F

M3 - Article

C2 - 15286542

AN - SCOPUS:3943071113

VL - 32

SP - 1669

EP - 1677

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 8

ER -